Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Jost

Showing results (71-80 of 202) with videos related to

Pageof 21
Sort By:
Applied Optics|February 28, 2008
Spatial shifts of the conjugate beam generated by a nondegenerate photorefractive phase-conjugate mirrorA A Al-Rashed, B M Jost, B E Saleh
Blood|October 15, 1996
Fate of contaminating t(14; 18)+ lymphoma cells during ex vivo expansion of CD34-selected hematopoietic progenitor cellsL Widmer, G Pichert, L M Jost, et al.
Acta Neurochirurgica|January 1, 1993
Surgical strategies and results in syringomyeliaV van Velthoven, M Jost, R Siekmann, et al.
Oncology|September 6, 2000
Risk-adapted chemotherapy of germ cell tumors with carboplatin, etoposide and bleomycin for low-risk and cisplatin, etoposide and ifosfamide for high-risk patients. A single-center studyG Tscherry, E Jacky, L M Jost, et al.
Schweizerische Medizinische Wochenschrift|November 6, 1982
[Inhibition and triggering of heart pacemakers by muscle potentials]M Jost, D Schelker, E Steinmann, et al.
Journal of Cell Science|January 1, 1997
Identification and characterization of a novel type of annexin-membrane interaction: Ca2+ is not required for the association of annexin II with early endosomesM Jost, D Zeuschner, J Seemann, et al.
British Journal of Cancer|February 1, 1991
Clinical and immune modulatory effects of alternative weekly interleukin-2 and interferon alfa-2a in patients with advanced renal cell carcinoma and melanomaG Pichert, L M Jost, W Fierz, et al.
Chest|February 1, 1984
Persisting symptoms despite permanent pacing. Incidence, causes, and follow-upA Hoffman, M Jost, M Pfisterer, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|September 10, 2005
The beta3-adrenergic agonist CL316,243 inhibits insulin signaling but not glucose uptake in primary human adipocytesM M Jost, P Jost, J Klein, et al.
Cancer Treatment Reviews|January 1, 1995
High-dose chemotherapy and autologous bone marrow transplantation for malignant lymphomasR A Stahel, L M Jost, G Pichert, et al.
Pageof 21

Showing results (71-80 of 202) with videos related to

Sort By:
Pageof 21
Applied Optics|February 28, 2008
Spatial shifts of the conjugate beam generated by a nondegenerate photorefractive phase-conjugate mirrorA A Al-Rashed, B M Jost, B E Saleh
Blood|October 15, 1996
Fate of contaminating t(14; 18)+ lymphoma cells during ex vivo expansion of CD34-selected hematopoietic progenitor cellsL Widmer, G Pichert, L M Jost, et al.
Acta Neurochirurgica|January 1, 1993
Surgical strategies and results in syringomyeliaV van Velthoven, M Jost, R Siekmann, et al.
Oncology|September 6, 2000
Risk-adapted chemotherapy of germ cell tumors with carboplatin, etoposide and bleomycin for low-risk and cisplatin, etoposide and ifosfamide for high-risk patients. A single-center studyG Tscherry, E Jacky, L M Jost, et al.
Schweizerische Medizinische Wochenschrift|November 6, 1982
[Inhibition and triggering of heart pacemakers by muscle potentials]M Jost, D Schelker, E Steinmann, et al.
Journal of Cell Science|January 1, 1997
Identification and characterization of a novel type of annexin-membrane interaction: Ca2+ is not required for the association of annexin II with early endosomesM Jost, D Zeuschner, J Seemann, et al.
British Journal of Cancer|February 1, 1991
Clinical and immune modulatory effects of alternative weekly interleukin-2 and interferon alfa-2a in patients with advanced renal cell carcinoma and melanomaG Pichert, L M Jost, W Fierz, et al.
Chest|February 1, 1984
Persisting symptoms despite permanent pacing. Incidence, causes, and follow-upA Hoffman, M Jost, M Pfisterer, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|September 10, 2005
The beta3-adrenergic agonist CL316,243 inhibits insulin signaling but not glucose uptake in primary human adipocytesM M Jost, P Jost, J Klein, et al.
Cancer Treatment Reviews|January 1, 1995
High-dose chemotherapy and autologous bone marrow transplantation for malignant lymphomasR A Stahel, L M Jost, G Pichert, et al.
Pageof 21